Export 179 results:
Author [ Title(Desc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
S
Ganesan S, Palani HKumar, Lakshmanan V, Balasundaram N, Alex AAbu, David S, Venkatraman A, Korula A, George B, Balasubramanian P, Palakodeti D, Vyas N, Mathews V.  2019.  Stromal cells downregulate miR-23a-5p to activate protective autophagy in acute myeloid leukemia.. Cell Death Dis. 10(10):736. DOI:10.1038/s41419-019-1964-8.
Kumari A, Singh D, Ramaswamy S, Ramanathan G.  2017.  Structural and functional studies of ferredoxin and oxygenase components of 3-nitrotoluene dioxygenase from Diaphorobacter sp. strain DS2.. PLoS One. 12(4):e0176398. DOI:10.1371/journal.pone.0176398.
Kumari A, Kesarwani S, Javoor MG, Vinothkumar KR, Sirajuddin M.  2020.  Structural insights into actin filament recognition by commonly used cellular actin markers.. EMBO J. 39(14):e104006. DOI:10.15252/embj.2019104006.
Kumari A, Kesarwani S, Javoor MG, Vinothkumar KR, Sirajuddin M.  2020.  Structural insights into actin filament recognition by commonly used cellular actin markers.. EMBO J. 39(14):e104006. DOI:10.15252/embj.2019104006.
Kurdekar V, Giridharan S, Subbarao J, Nijaguna MB, Periasamy J, Boggaram S, Shivange AV, Sadasivam G, Padigaru M, Potluri V, Venkitaraman AR, Bharatham K.  2019.  Structure-Guided Synthesis and Evaluation of Small-Molecule Inhibitors Targeting Protein-Protein Interactions of BRCA1 tBRCT Domain.. ChemMedChem. 14(18):1620-1632. DOI:10.1002/cmdc.201900300.
Asiminas A, Jackson AD, Louros SR, Till SM, Spano T, Dando O, Bear MF, Chattarji S, Hardingham GE, Osterweil EK, Wyllie DJA, Wood ER, Kind PC.  2019.  Sustained correction of associative learning deficits after brief, early treatment in a rat model of Fragile X Syndrome.. Sci Transl Med. 11(494) DOI:10.1126/scitranslmed.aao0498.
T
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..  2024.  TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..  2024.  TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..  2024.  TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..  2024.  TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
Raote I, Rosendahl A-H, Häkkinen H-M, Vibe C, Küçükaylak I, Sawant M, Keufgens L, Frommelt P, Halwas K, Broadbent K, Cunquero M, Castro G, Villemeur M, Nüchel J, Bornikoel A, Dam B, Zirmire RK, Kiran R, Carolis C, Andilla J et al..  2024.  TANGO1 inhibitors reduce collagen secretion and limit tissue scarring.. Nat Commun. 15(1):3302. DOI:10.1038/s41467-024-47004-1.
Emery A, Hardwick BS, Crooks AT, Milech N, Watt PM, Mithra C, Kumar V, Giridharan S, Sadasivam G, Mathivanan S, Sudhakar S, Bairy S, Bharatham K, Hurakadli MA, Prasad TK, Kamariah N, Muellner M, Coelho M, Torrance CJ, McKenzie GJ et al..  2021.  Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide library.. Cell Chem Biol. DOI:10.1016/j.chembiol.2021.05.009.
Emery A, Hardwick BS, Crooks AT, Milech N, Watt PM, Mithra C, Kumar V, Giridharan S, Sadasivam G, Mathivanan S, Sudhakar S, Bairy S, Bharatham K, Hurakadli MA, Prasad TK, Kamariah N, Muellner M, Coelho M, Torrance CJ, McKenzie GJ et al..  2021.  Target identification for small-molecule discovery in the FOXO3a tumor-suppressor pathway using a biodiverse peptide library.. Cell Chem Biol. DOI:10.1016/j.chembiol.2021.05.009.
Kumar V, Lakshman PKumar Chun, Prasad TKootteri, Manjunath K, Bairy S, Vasu AS, Ganavi B, Jasti S, Kamariah N.  2024.  Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening.. Heliyon. 10(1):e23864. DOI:10.1016/j.heliyon.2023.e23864.
Kumar V, Lakshman PKumar Chun, Prasad TKootteri, Manjunath K, Bairy S, Vasu AS, Ganavi B, Jasti S, Kamariah N.  2024.  Target-based drug discovery: Applications of fluorescence techniques in high throughput and fragment-based screening.. Heliyon. 10(1):e23864. DOI:10.1016/j.heliyon.2023.e23864.
Singh R, Hegde B, Von Baby B, Sadeep C, Kotla N, Chandrasekar B, Marepally S, Bodduluri H, Vemula PK, Jala VR.  2017.  Targeted delivery of microbial metabolite, urolithin A protects from chemically (DSS or TNBS) induced colitis in pre-clinical models. The Journal of Immunology. 198:65.6–65.6.
Periasamy J, Kurdekar V, Jasti S, Nijaguna MB, Boggaram S, Hurakadli MA, Raina D, Kurup LMeenakshi, Chintha C, Manjunath K, Goyal A, Sadasivam G, Bharatham K, Padigaru M, Potluri V, Venkitaraman AR.  2018.  Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling.. Cell Chem Biol. 25(6):677-690.e12. DOI:10.1016/j.chembiol.2018.02.012.
Periasamy J, Kurdekar V, Jasti S, Nijaguna MB, Boggaram S, Hurakadli MA, Raina D, Kurup LMeenakshi, Chintha C, Manjunath K, Goyal A, Sadasivam G, Bharatham K, Padigaru M, Potluri V, Venkitaraman AR.  2018.  Targeting Phosphopeptide Recognition by the Human BRCA1 Tandem BRCT Domain to Interrupt BRCA1-Dependent Signaling.. Cell Chem Biol. 25(6):677-690.e12. DOI:10.1016/j.chembiol.2018.02.012.
SOLOMON JOHN, KALAISELVI VS, KALAIVANI MK, NEHIL JUWAINSHEHZAD, JOHNSON WMS, SAIKUMAR CHITRALEKA, CHRISTUDASS CHRISTHUNESASOUNDARARA, RANI SANDYA.  2024.  T-cell Response after COVID-19 Vaccination: A Cross-sectional Study.. Journal of Clinical & Diagnostic Research. 18
SOLOMON JOHN, KALAISELVI VS, KALAIVANI MK, NEHIL JUWAINSHEHZAD, JOHNSON WMS, SAIKUMAR CHITRALEKA, CHRISTUDASS CHRISTHUNESASOUNDARARA, RANI SANDYA.  2024.  T-cell Response after COVID-19 Vaccination: A Cross-sectional Study.. Journal of Clinical & Diagnostic Research. 18
Kumar VPraveen, Kishi Y.  2020.  Total Synthesis of Halistatins 1 and 2.. J Am Chem Soc. 142(34):14743-14749. DOI:10.1021/jacs.0c07390.
Kumar VPraveen, Kishi Y.  2020.  Total Synthesis of Halistatins 1 and 2.. J Am Chem Soc. 142(34):14743-14749. DOI:10.1021/jacs.0c07390.
Joshi N, Yan J, Levy S, Bhagchandani S, Slaughter KV, Sherman NE, Amirault J, Wang Y, Riegel L, He X, Rui TShi, Valic M, Vemula PK, Miranda OR, Levy O, Gravallese EM, Aliprantis AO, Ermann J, Karp JM.  2018.  Towards an arthritis flare-responsive drug delivery system.. Nat Commun. 9(1):1275. DOI:10.1038/s41467-018-03691-1.
Krishna S, Raghavan S, DasGupta R, Palakodeti D.  2021.  tRNA-derived fragments (tRFs): establishing their turf in post-transcriptional gene regulation.. Cell Mol Life Sci. DOI:10.1007/s00018-020-03720-7.
U
Bhattacharjee O, Ayyangar U, Kurbet AS, Ashok D, Raghavan S.  2019.  Unraveling the ECM-Immune Cell Crosstalk in Skin Diseases.. Front Cell Dev Biol. 7:68. DOI:10.3389/fcell.2019.00068.
Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA, Joshi C, Rangappa S, Castellanos J, Vemula PKumar, Chen X, Kwon D, Kashikar N, VanSaun M, Merchant NB, Nagathihalli NS.  2019.  Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.. Mol Cancer Ther. 18(2):301-311. DOI:10.1158/1535-7163.MCT-18-0464.
Totiger TM, Srinivasan S, Jala VR, Lamichhane P, Dosch AR, Gaidarski AA, Joshi C, Rangappa S, Castellanos J, Vemula PKumar, Chen X, Kwon D, Kashikar N, VanSaun M, Merchant NB, Nagathihalli NS.  2019.  Urolithin A, a Novel Natural Compound to Target PI3K/AKT/mTOR Pathway in Pancreatic Cancer.. Mol Cancer Ther. 18(2):301-311. DOI:10.1158/1535-7163.MCT-18-0464.
W
Purushothaman G, Juvale K, Kirubakaran S, Vemula PKumar, Thiruvenkatam V.  2017.  Water-mediated intermolecular interactions in 1,2-O-cyclohexylidene-myo-inositol: a quantitative analysis.. Acta Crystallogr C Struct Chem. 73(Pt 1):20-27. DOI:10.1107/S2053229616018581.
Z
Sunnap O, Subramanian S, Vemula PKumar, Karuppannan S.  2022.  Zingerone-encapsulated Solid Lipid Nanoparticles as Oral Drug-delivery Systems to Potentially Target Inflammatory Diseases. ChemNanoMat. 8 DOI:10.1002/cnma.202200388.

Pages